Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0001209191-23-014603

Options or other derivatives

  • Chief Financial Officer acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Giacobello Scott M. Chief Financial Officer 2023-03-01 Grant or award · Stock option (right to buy) +90,000 90,000 D
Loading xslF345X03/doc4.xml…